In the study of Mazoujian et al. (1978), it was observed that 55% of the studied breast carcinoma was positive for GCDFP-15 marker expressions, which were 23% in breast carcinoma without apocrine features and 75% in breast carcinoma with apocrine features. This evidence concerns the gene PIP and breast carcinoma.